Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2000 1
2002 1
2003 3
2004 2
2005 1
2006 3
2007 2
2008 2
2009 3
2010 12
2011 8
2012 6
2013 3
2014 5
2015 9
2016 3
2017 3
2018 6
2019 7
2020 8
2021 3
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
BACKGROUND: Pembrolizumab monotherapy showed durable antitumour activity and manageable safety in patients with metastatic triple-negative breast cancer. We aimed to examine whether the addition of pembrolizumab would enhance the antitumour activity of chemotherapy in pati …
BACKGROUND: Pembrolizumab monotherapy showed durable antitumour activity and manageable safety in patients with metastatic triple-negative b …
Voice for Vesna.
Marusić A. Marusić A. Croat Med J. 2011 Apr 15;52(2):214. doi: 10.3325/cmj.2011.52.214. Croat Med J. 2011. PMID: 21495206 Free PMC article. No abstract available.
Overview of Cadmium Thyroid Disrupting Effects and Mechanisms.
Buha A, Matovic V, Antonijevic B, Bulat Z, Curcic M, Renieri EA, Tsatsakis AM, Schweitzer A, Wallace D. Buha A, et al. Int J Mol Sci. 2018 May 17;19(5):1501. doi: 10.3390/ijms19051501. Int J Mol Sci. 2018. PMID: 29772829 Free PMC article. Review.
A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.
Levavi H, Tripodi J, Marcellino B, Mascarenhas J, Jones AV, Cross NCP, Gruenstein D, Najfeld V. Levavi H, et al. Acta Haematol. 2019;142(2):105-112. doi: 10.1159/000498945. Epub 2019 May 7. Acta Haematol. 2019. PMID: 31063994 Free article. Review.
The JAK2V617F point mutation has been implicated in the pathogenesis of the vast majority of myeloproliferative neoplasms (MPNs), but translocations involving JAK2 have increasingly been identified in patients with JAK2V617F-negativeMPNs. ...
The JAK2V617F point mutation has been implicated in the pathogenesis of the vast majority of myeloproliferative neoplasms (MPNs), but …
Words heal too.
Andrijević-Matovac V. Andrijević-Matovac V. Croat Med J. 2010 Apr;51(2):173-6. doi: 10.3325/cmj.2010.51.173. Croat Med J. 2010. PMID: 20401962 Free PMC article. No abstract available.
Pink ribbon day.
Andrijević-Matovac V. Andrijević-Matovac V. Croat Med J. 2009 Oct;50(5):515-6. doi: 10.3325/cmj.2009.50.515. Croat Med J. 2009. PMID: 19839077 Free PMC article. No abstract available.
Current concepts in the diagnosis of transverse myelopathies.
Brinar VV, Habek M, Zadro I, Barun B, Ozretić D, Vranjes D. Brinar VV, et al. Clin Neurol Neurosurg. 2008 Nov;110(9):919-27. doi: 10.1016/j.clineuro.2008.07.002. Epub 2008 Aug 20. Clin Neurol Neurosurg. 2008. PMID: 18718707 Free article. Review.
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
Bisof V, Rakusic Z, Despot M. Bisof V, et al. Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1553-67. doi: 10.1007/s00405-014-3108-1. Epub 2014 Jun 3. Eur Arch Otorhinolaryngol. 2015. PMID: 24890977 Review.
Anaplastic thyroid cancer (ATC) is one of the most deadly cancers in humans. Searching a PubMed database, studies published during the last 20 years, 63 publications dealing with treatment of patients were identified. ...
Anaplastic thyroid cancer (ATC) is one of the most deadly cancers in humans. Searching a PubMed database, studies published du …
The light from Bethlehem.
Andrijević-Matovac V. Andrijević-Matovac V. Croat Med J. 2010 Dec;51(6):563-7. doi: 10.3325/cmj.2010.51.563. Croat Med J. 2010. PMID: 21162170 Free PMC article. No abstract available.
83 results